Logo visoto
  1. Home
Page icon

SELECT ?title WHERE { ?? (rdfs:label|skos:prefLabel|schema:name) ?title . } mRNA-Impfstoff

SELECT ?class WHERE { ?? (rdf:type|owl:type) ?class . } DefinedTerm, Term, Validated Entry

SELECT ?description WHERE { ?? (rdfs:comment|schema:description) ?description . }

SELECT ?property ?value WHERE { BIND (?? AS ?s) ?s ?property ?value . FILTER (isLiteral(?value)) } LIMIT 1000

Attributes

Name
mRNA-Impfstoff
Name
mRNA vaccine
Name
vaccin à ARNm
Name
vaccino a mRNA
dateModified
2022-07-01T08:35:52.4499810Z
Identifier
480435
URL
https://www.termdat.bk.admin.ch/entry/480435
citation
Pfizer, Behind the Science: what is an mRNA Vaccine?, 2020-08-25 ([Internet, 2020-12-22](https://www.pfizer.co.uk/behind-science-what-mrna-vaccine))
citation
Swissmedic, So schützen mRNA-Impfstoffe vor dem Corona-Virus, 2020-12 ([Internet, 2020-12-28](https://www.swissmedic.ch/dam/swissmedic/de/dokumente/zulassung/zl_hmv_iv/factsheet-mrna-impfstoffe.pdf.download.pdf/Swissmedic-Factsheet-mRNA-Impfstoffe_de.pdf))
citation
Swissmedic, Comment les vaccins à ARNm protègent contre le coronavirus, 2020-12 ([Internet, 2020-12-28](https://www.swissmedic.ch/dam/swissmedic/fr/dokumente/zulassung/zl_hmv_iv/factsheet-mrna-impfstoffe.pdf.download.pdf/Swissmedic-Factsheet-mRNA-Impfstoffe_fr.pdf))
citation
Swissmedic, Come i vaccini a mRNA proteggono dal coronavirus, 2020-12 ([Internet, 2020-12-28](https://www.swissmedic.ch/dam/swissmedic/it/dokumente/zulassung/zl_hmv_iv/factsheet-mrna-impfstoffe.pdf.download.pdf/Swissmedic-Factsheet-mRNA-Impfstoffe_it.pdf))
position
1
Linguistic Context
Bei den Covid-19[-]Impfstoffen von Pfizer-BioNTech sowie Moderna handelt es sich um mRNA-Impfstoffe. Bei dieser Methode wird ein winziges Stückchen Bauplan des neuartigen Coronavirus (SARS-CoV-2) verwendet, um dem Körper eine Abwehrreaktion beizubringen. Messenger-Ribonukleinsäuren (mRNA) sind Botenmoleküle, die Baupläne des Erregers in die menschlichen Zellen tragen. [...] [Daraufhin] wird nach diesen Plänen ein Oberflächen-Protein gebaut, beim SARS-CoV-2 das so genannte Spike-Protein. Das Immunsystem erkennt dieses als fremd und bildet dagegen Antikörper.
Linguistic Context
I vaccini anti-Covid-19 di Pfizer-BioNTech e Moderna sono vaccini a mRNA. Con questo metodo, una piccola parte del materiale genetico del nuovo coronavirus (SARS-CoV-2) viene utilizzata per indurre una risposta immunitaria nell’organismo. Gli acidi ribonucleici messaggeri (mRNA) sono molecole messaggere che trasportano l’informazione genetica dell’agente patogeno nelle cellule umane, in cui viene costruita una proteina di superficie sulla base di questa informazione, la cosiddetta proteina spike del SARS-CoV-2. Il sistema immunitario la riconosce come estranea e crea gli anticorpi per combatterla.
Linguistic Context
Les vaccins contre le COVID-19 de Pfizer-BioNTech et de Moderna sont, eux, des vaccins à ARNm. Dans ce cas, un minuscule fragment du plan de construction du nouveau coronavirus (SARS-CoV-2) est utilisé pour apprendre à l’organisme à se défendre. Les ARN messagers (acides ribonucléiques messagers, ARNm) sont des molécules qui transportent les plans de construction de l’agent pathogène jusque dans les cellules humaines, où ces plans sont utilisés pour construire une protéine de surface, la protéine Spike dans le cas du SARS-CoV-2. Le système immunitaire identifie cette protéine comme étrangère à l’organisme et fabrique des anticorps pour la combattre.
Term Note
DOM: pandemia di COVID-19
Term Note
DOM: Covid-19-Pandemie
Term Note
DOM: COVID-19 pandemic
Term Note
DOM: pandémie de COVID-19
SELECT ?property ?object WHERE { BIND (?? AS ?s) ?s ?property ?object . FILTER (isIRI(?object)) FILTER (?property != rdf:type) FILTER (?property != rdfs:subClassOf) } LIMIT 1000

Outgoing Relationships

property object
seeAlso messenger RNA
seeAlso vaccine
inDefinedTermSet Terminology of the communicable diseases
inDefinedTermSet Swiss Federal Administration
inDefinedTermSet Terminology of the COVID-19 pandemic
has part Boten-RNA-Impfstoff
has part RNA vaccine
has part vaccin à ARN
has part vaccino a RNA messaggero
has part RNA-Impfstoff
has part messenger RNA vaccine
has part vaccin à ARN messager
has part vaccino a RNA
has part RNS-Impfstoff
Reliability code Linguistic/formal check completed
termDomain MEDICINE
termDomain Health care
SELECT ?property ?subject WHERE { BIND (?? AS ?o) ?subject ?property ?o . FILTER (?property != rdf:type) FILTER (?property != rdfs:subClassOf) } LIMIT 1000

Incoming Relationships

property subject
seeAlso messenger RNA
seeAlso vector vaccine
seeAlso protein vaccine
SELECT ?instance ?description WHERE { BIND (?? AS ?class) ?instance (rdf:type|owl:type) ?class . OPTIONAL { ?instance schema:description ?description . } } LIMIT 5000
Instances of this Class: No results found.
SELECT ?superclass ?description WHERE { ?? rdfs:subClassOf ?superclass . OPTIONAL { ?superclass (rdfs:comment|schema:description) ?description . } } LIMIT 5000
Superclasses of this Class: No results found.
SELECT ?subclass ?description WHERE { ?subclass rdfs:subClassOf ?? . OPTIONAL { ?subclass (rdfs:comment|schema:description) ?description . } } LIMIT 5000
Subclasses of this Class: No results found.